My NCBISign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 135

    1.

    Generic drug policy in Australia: a community pharmacy perspective.

    Beecroft G.

    Aust New Zealand Health Policy. 2007 Jun 1;4:7.PMID: 17543112 [PubMed]Related articlesFree article

    2.

    Do generics offer significant savings to the UK National Health Service?

    Kanavos P.

    Curr Med Res Opin. 2007 Jan;23(1):105-16.PMID: 17257472 [PubMed - indexed for MEDLINE]Related articles

    3.

    High prices for generics in Australia - more competition might help.

    Bulfone L.

    Aust Health Rev. 2009 May;33(2):200-14.PMID: 19563309 [PubMed - in process]Related articles

    4.

    Evolution of antiretroviral drug costs in Brazil in the context of free and universal access to AIDS treatment.

    Nunn AS, Fonseca EM, Bastos FI, Gruskin S, Salomon JA.

    PLoS Med. 2007 Nov 13;4(11):e305.PMID: 18001145 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Evaluating drug prices, availability, affordability, and price components: implications for access to drugs in Malaysia.

    Babar ZU, Ibrahim MI, Singh H, Bukahri NI, Creese A.

    PLoS Med. 2007 Mar 27;4(3):e82.PMID: 17388660 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    The global biopharma industry and the rise of Indian drug multinationals: implications for Australian generics policy.

    Löfgren H.

    Aust New Zealand Health Policy. 2007 Jun 1;4:10.PMID: 17543115 [PubMed]Related articlesFree article

    7.

    University contributions to the HPV vaccine and implications for access to vaccines in developing countries: addressing materials and know-how in university technology transfer policy.

    Crager SE, Guillen E, Price M.

    Am J Law Med. 2009;35(2-3):253-79.PMID: 19697749 [PubMed - indexed for MEDLINE]Related articles

    8.

    Formulary management in the Department of Defense.

    Trice S, Devine J, Mistry H, Moore E, Linton A.

    J Manag Care Pharm. 2009 Mar;15(2):133-46.PMID: 19236127 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Pharmacy discounts on generic medicines in France: is there room for further efficiency savings?

    Kanavos P, Taylor D.

    Curr Med Res Opin. 2007 Oct;23(10):2467-76.PMID: 17764613 [PubMed - indexed for MEDLINE]Related articles

    10.

    Generic drugs: international trends and policy developments in Australia.

    Lofgren H.

    Aust Health Rev. 2004;27(1):39-48.PMID: 15362295 [PubMed - indexed for MEDLINE]Related articles

    11.

    Challenges for Australia's Bio/Nanopharma Policies: trade deals, public goods and reference pricing in sustainable industrial renewal.

    Faunce TA.

    Aust New Zealand Health Policy. 2007 Jun 1;4:9.PMID: 17543114 [PubMed]Related articlesFree article

    12.

    Case study of the effects of office-based generic drug sampling on antibiotic drug costs and first-line antibiotic prescribing ratios.

    Conklin MH, Culley EJ, O'Donnell J.

    J Manag Care Pharm. 2009 Jan-Feb;15(1):55-61.PMID: 19125550 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Historical overview of generic medication policy.

    Ascione FJ, Kirking DM, Gaither CA, Welage LS.

    J Am Pharm Assoc (Wash). 2001 Jul-Aug;41(4):567-77.PMID: 11486983 [PubMed - indexed for MEDLINE]Related articles

    14.

    Systems for the management of respiratory disease in primary care - an international series: Australia.

    Glasgow N.

    Prim Care Respir J. 2008 Mar;17(1):19-25. Review.PMID: 18322632 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Reference pricing, generic drugs and proposed changes to the Pharmaceutical Benefits Scheme.

    Searles A, Jefferys S, Doran E, Henry DA.

    Med J Aust. 2007 Aug 20;187(4):236-9. Epub 2007 Jun 13. Review.PMID: 17564580 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Factors associated with choice of pharmacy setting among DoD health care beneficiaries aged 65 years or older.

    Linton A, Garber M, Fagan NK, Peterson M.

    J Manag Care Pharm. 2007 Oct;13(8):677-86.PMID: 17970605 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    A comparison of mail-service and retail community pharmacy claims in 5 prescription benefit plans.

    Clark BE, Siracuse MV, Garis RI.

    Res Social Adm Pharm. 2009 Jun;5(2):133-42. Epub 2009 Jan 31.PMID: 19524861 [PubMed - indexed for MEDLINE]Related articles

    18.

    Pharmaceutical care in community pharmacies: practice and research in Estonia.

    Volmer D, Vendla K, Vetka A, Bell JS, Hamilton D.

    Ann Pharmacother. 2008 Jul;42(7):1104-11. Epub 2008 Jun 24.PMID: 18577761 [PubMed - indexed for MEDLINE]Related articles

    19.

    Transparency in pricing arrangements for medicines listed on the Australian Pharmaceutical Benefits Scheme.

    Robertson J, Walkom EJ, Henry DA.

    Aust Health Rev. 2009 May;33(2):192-9.PMID: 19563308 [PubMed - in process]Related articles

    20.

    Prices & availability of common medicines at six sites in India using a standard methodology.

    Kotwani A, Ewen M, Dey D, Iyer S, Lakshmi PK, Patel A, Raman K, Singhal GL, Thawani V, Tripathi S, Laing R.

    Indian J Med Res. 2007 May;125(5):645-54.PMID: 17642500 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity

    You are here: NCBI > Literature > PubMed
    Write to the Help Desk